KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
17.30
+1.07 (6.59%)
At close: Mar 9, 2026, 4:00 PM EDT
17.31
+0.01 (0.08%)
After-hours: Mar 9, 2026, 7:19 PM EDT
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of $874.45 million as of March 9, 2026. Its market cap has increased by 66.31% in one year.
Market Cap
874.45M
Enterprise Value
821.45M
1-Year Change
66.31%
Ranking
Category
Stock Price
$17.30
Market Cap Chart
Since April 9, 2015, KalVista Pharmaceuticals's market cap has increased from $129.30M to $874.45M, an increase of 576.30%. That is a compound annual growth rate of 19.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 820.40M | 0.50% |
| Dec 31, 2025 | 816.30M | 95.01% |
| Dec 31, 2024 | 418.60M | -1.11% |
| Dec 29, 2023 | 423.30M | 154.39% |
| Dec 30, 2022 | 166.40M | -48.59% |
| Dec 31, 2021 | 323.70M | -4.99% |
| Dec 31, 2020 | 340.70M | 7.27% |
| Dec 31, 2019 | 317.60M | -6.64% |
| Dec 31, 2018 | 340.20M | 223.69% |
| Dec 29, 2017 | 105.10M | 690.23% |
| Dec 30, 2016 | 13.30M | -86.04% |
| Dec 31, 2015 | 95.30M | -26.30% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Janux Therapeutics | 841.91M |
| Phathom Pharmaceuticals | 840.78M |
| Sana Biotechnology | 840.63M |
| Evommune | 835.39M |
| BridgeBio Oncology Therapeutics | 833.94M |
| Xencor | 830.19M |
| Omeros | 818.19M |
| MapLight Therapeutics | 807.80M |